Arkady Ovchinnikov (A Ovchinnikov)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Optical Coherence Tomography

Multiple Sclerosis

Brain Metastases

Immune Response

Top Venues

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Wiener medizinische Wochenschrift (1946)

This page only lists publications with an associated author ORCID identifier.

Publications

Arkady Ovchinnikov, L Andereggen, S Rogers, Markus Gschwind
Visual hallucinations after resection of cerebral metastases: two patients with complex phantom images. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 200 (9) (2024)
Arkady Ovchinnikov, L Andereggen, S Rogers, Markus Gschwind
Visual hallucinations after resection of cerebral metastases: two patients with complex phantom images. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
Arkady Ovchinnikov, L Andereggen, S Rogers, Markus Gschwind
Visual hallucinations after resection of cerebral metastases: two patients with complex phantom images. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 200 (9) (2024)
Arkady Ovchinnikov, L Andereggen, S Rogers, Markus Gschwind
Visual hallucinations after resection of cerebral metastases: two patients with complex phantom images. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 200 (9) (2024)
Arkady Ovchinnikov, L Andereggen, S Rogers, Markus Gschwind
Visual hallucinations after resection of cerebral metastases: two patients with complex phantom images. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 200 (9) (2024)
Jens Kuhle, Arkady Ovchinnikov, Barbara Jakopp, Michael Oberle, Krassen Nedeltchev, Christoph Andreas Fux, Johann Sellner, Oliver Findling
SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot. Vaccines 10 (2) (2022)
Arkady Ovchinnikov, Oliver Findling
An overview of pivotal trials and real-world evidence for CD20-depleting therapy in multiple sclerosis : Immunotherapy with rituximab, ocrelizumab, and ofatumumab. Wiener medizinische Wochenschrift (1946) 172 (15-16) (2022)